topiramate

Generic: topiramate

Labeler: cipla usa inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name topiramate
Generic Name topiramate
Labeler cipla usa inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

topiramate 200 mg/1

Manufacturer
Cipla USA Inc.

Identifiers & Regulatory

Product NDC 69097-125
Product ID 69097-125_71f493d9-3aaa-4b13-8057-012e96e11dbc
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA076343
Listing Expiration 2026-12-31
Marketing Start 2014-06-12

Pharmacologic Class

Mechanism of Action
cytochrome p450 3a4 inducers [moa] cytochrome p450 2c19 inhibitors [moa]
Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69097125
Hyphenated Format 69097-125

Supplemental Identifiers

RxCUI
151226 199888 199889 199890
UNII
0H73WJJ391
NUI
N0000008486 N0000185506 N0000182140

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name topiramate (source: ndc)
Generic Name topiramate (source: ndc)
Application Number ANDA076343 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (69097-125-03)
  • 500 TABLET in 1 BOTTLE (69097-125-12)
  • 1000 TABLET in 1 BOTTLE (69097-125-15)
source: ndc

Packages (3)

69097-125-03 60 TABLET in 1 BOTTLE (69097-125-03) 69097-125-12 500 TABLET in 1 BOTTLE (69097-125-12) 69097-125-15 1000 TABLET in 1 BOTTLE (69097-125-15)

Ingredients (1)

topiramate (200 mg/1)

Linked Drug Pages (1)

Topiramate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "71f493d9-3aaa-4b13-8057-012e96e11dbc", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["151226", "199888", "199889", "199890"], "spl_set_id": ["ca4ec248-285d-4066-8f89-5ed0c538c4c9"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (69097-125-03)", "package_ndc": "69097-125-03", "marketing_start_date": "20140612"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (69097-125-12)", "package_ndc": "69097-125-12", "marketing_start_date": "20140612"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (69097-125-15)", "package_ndc": "69097-125-15", "marketing_start_date": "20140612"}], "brand_name": "Topiramate", "product_id": "69097-125_71f493d9-3aaa-4b13-8057-012e96e11dbc", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "69097-125", "generic_name": "Topiramate", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "200 mg/1"}], "application_number": "ANDA076343", "marketing_category": "ANDA", "marketing_start_date": "20140612", "listing_expiration_date": "20261231"}